SPECTROLYSE HEPARIN (ANTI-IIA)— 510(k) K972209

Substantially Equivalent

Medical Diagnostic Technologies, Inc.

FDA 510(k) clearance K972209 for SPECTROLYSE HEPARIN (ANTI-IIA), Substantially Equivalent on 1997-08-12. Applicant: Medical Diagnostic Technologies, Inc..

Clearance details

Applicant
Medical Diagnostic Technologies, Inc.
Product code
Code KFF
Advisory panel
Hematology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Ventura, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.